Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 4—April 2019

Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men

Tim R.H. Read, Gerald L. Murray, Jennifer A. Danielewski, Christopher K. Fairley, Michelle Doyle, Karen Worthington, Jenny Su, Elisa Mokany, L.T. Tan, David Lee, Lenka A. Vodstrcil, Eric P.F. Chow, Suzanne M. Garland, Marcus Y. Chen, and Catriona S. BradshawComments to Author 
Author affiliations: Melbourne Sexual Health Centre, Carlton, Victoria, Australia (T.R.H. Read, C.K. Fairley, M. Doyle, K. Worthington, D. Lee, L.A. Vodstrcil, E.P.F. Chow, M.Y. Chen, C.S. Bradshaw); Monash University, Melbourne, Victoria, Australia (T.R.H. Read, C.K. Fairley, L.A. Vodstrcil, E.P.F. Chow, M.Y. Chen, C.S. Bradshaw); Monash Biomedicine Discovery Institute, Melbourne (G.L. Murray); Murdoch Children’s Research Institute, Parkville, Victoria, Australia (G.L. Murray, J.A. Danielewski, J. Su, S.M. Garland); Royal Women’s Hospital, Melbourne (G.L. Murray, J.A. Danielewski, S.M. Garland); Royal Children’s Hospital, Melbourne (G.L. Murray, S.M. Garland); SpeeDx Pty Ltd, Eveleigh, Sydney, New South Wales, Australia (E. Mokany, L.T. Tan); University of Melbourne, Melbourne (S.M. Garland)

Main Article

Table 5

Risk factors for detection of macrolide resistance mutations in anogenital Mycoplasma genitalium infections detected in men who have sex with men, Australia

Mutations not detected, no. (%)
Mutations detected, no. (%)
p value
15 (15.8)
80 (84.2)

Antibiotic in the preceding 3 months
None 13 (86.7) 54 (67.5)
Yes, not azithromycin 2 (13.3) 17 (21.3)
Yes, azithromycin
9 ( 11.2)
HIV status
Negative 15 (100.0) 75 (93.8)
5 ( 6.2)
Taking or starting PrEP*
No 15 (100.0) 59 (78.7)
16 (21.3)
Site of infection
Urine 4 (26.7) 23 (28.0)
Rectum 11 (73.3) 59 (72.2) 0.91

*PrEP, preexposure prophylaxis. HIV-positive men excluded.

Main Article

Page created: March 18, 2019
Page updated: March 18, 2019
Page reviewed: March 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.